Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321945 · ClinicalTrials.gov registry record
A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 546
- Enrollment target
NCT00321945 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 546 participants.
The verdict
NCT00321945 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 546 participants
- Enrollment target
Study Summary
It is well known that atrial fibrillation (AF) and atrial flutter occur frequently after most types of cardiac surgeries.(1-4) Postoperative AF is associated with significant morbidity, longer hospital stay, and higher related costs. Currently, it is common procedure to premedicate patients with antiarrhythmic drugs for elective cardiac surgeries. Treatments such as beta blockers, Amiodarone, and electrical pacing are used to help prevent the morbidity associated with pot-operative AF.(5) Renin-angiotensin system (RAS) activation may contribute to AF. Several clinical trials have suggested that inhibitors of this system may reduce the incidence of AF.(6-12) Patients with AF are known to have increased levels of angiotensin converting enzyme (ACE) and some types of angiotensin receptors.(13-15) Data from animal studies performed by our group suggest that cardiac ACE overexpression may lead to arrhythmic ion channel changes.(16;17) Although not studied in this group yet, it would be reasonable to conclude that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) would decrease the incidence of AF in post-operative patients, too
Interventions
- PROCEDURE ACE-Inhibitors and Angiotensin Receptor Blockers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00321945
The ClinicalTrials.gov registry entry for NCT00321945 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACE-Inhibitors and Angiotensin Receptor Blockers is the first listed.
NCT00321945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00321945 about?
NCT00321945 is a clinical study titled "A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers". It is well known that atrial fibrillation (AF) and atrial flutter occur frequently after most types of cardiac surgeries.(1-4) Postoperative AF is associated with significant morbidity, longer hospital stay, and higher related costs. Currently, it is common procedure to premedicate patients with ant...
What is the current status of trial NCT00321945?
This trial is currently completed. The enrollment target is 546 participants. The study started on 2005-12. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00321945?
The interventions under investigation include: ACE-Inhibitors and Angiotensin Receptor Blockers (PROCEDURE).
Who is sponsoring clinical trial NCT00321945?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.